Responses to Drs. Kim and Dionne regarding comments on Diatchenko, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125:216-24 Dear Editor,
We would like to thank Drs. Kim and Dionne for their thoughtful comments regarding our paper Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli that was published in the December issue of Pain. We enthusiastically support their desire to maintain rigorous standards for studies in the area of pain genetics and we also appreciate the opportunity to address the key concerns and criticisms that Kim and Dionne have raised about our publication. The impact of population stratification and phenotyping procedures should be taken into account by any genetic association study. While these study design concerns were not specifically discussed in the December article, they are issues that we have carefully considered and largely addressed in past publications pertaining to this patient population. (Diatchenko et al., 2005; Bhalang et al., 2005) .
The first concern raised by Kim and Dionne relates to the problem of false genetic associations that can occur as a result of population stratification. The patterns of genetic variations (Pritchard and Rosenberg, 1999; Gabriel et al., 2002) and pain sensitivity (Edwards et al., 2001) are not uniform between ethnically diverse populations. However, population stratification may lead to spurious associations only when the specific investigated phenotype as well as genotype distributions are not the same among the different ethnic groups in the cohort considered (Enoch et al., 2006) . Because our recruited population was ethnically mixed, we investigated this important issue and reported the outcome of the analysis in a previous publication (Diatchenko et al., 2005) . We viewed this verification as a ''best practice'' and because of space limitations we did not include a detailed analysis in the December article. Briefly, there were too few non-Caucasian participants (N = 31; 15%) genotyped to permit meaningful statistical analyses by treating this group as a separate stratum. In addition, the percentage of subjects classified as HPS/APS was virtually identical between Caucasians (35%) and non-Caucasians (36% -Chi-square test, P = 0.89) and the mean derived measure of global pain sensitivity (pain z-score) did not differ between the two groups (t-test,
